Conditions: Hemorrhage
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 1
Healthy volunteers: no

Brief summary:
The objective is to collect the safety data of idarucizumab for patients treated with dabigatran who require rapid reversal of the anticoagulant effects of dabigatran in cases of uncontrolled or life-threatening bleeding or when emergency surgery or urgent procedures are required.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: idarucizumab
Intervention descriptions: intervention 1: None

Protocol document: